A phase I and pharmacologic study of sequences of the proteasome inhibitor, bortezomib (PS-341, Velcade), in combination with paclitaxel and carboplatin in patients with advanced malignancies.
Cancer Chemother Pharmacol
; 59(2): 207-15, 2007 Feb.
Article
em En
| MEDLINE
| ID: mdl-16763792
Buscar no Google
Base de dados:
MEDLINE
Assunto principal:
Protocolos de Quimioterapia Combinada Antineoplásica
/
Inibidores de Proteassoma
/
Neoplasias
Idioma:
En
Ano de publicação:
2007
Tipo de documento:
Article